ISSN: 0973-7510

E-ISSN: 2581-690X

CAG Yasemin1, Gencer Serap1, AK. Oznur1 , CAG Yakup2 and Ozer Serdar1
1Dr.Lütfi Kirdar Kartal Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey.
2Sultanbeyli State Hospital, Department of Pediatrics, Istanbul /Turkey.
J Pure Appl Microbiol. 2013;7(2):1367-1371
© The Author(s). 2013
Received: 18/09/2012 | Accepted: 25/11/2012 | Published: 30/06/2013
Abstract

The incidence of nosocomial infections due to vancomycin-resistant enterococci(VRE) has been increasing dramatically and the treatment of these infections has been challenging. The aim of this study was to evaluated the activity of linezolid, daptomycin, quinupristin-dalfopristin and tigecycline against VRE isolates. One hundred VRE isolates collected from surveillance and clinical specimens of patients in the intensive care units(ICUs) and pediatric clinics of our hospital between April 2007 and February 2010, and as a control group, 30vancomycin-sensitive enterococci(VSE) isolates from blood or urine cultures were included in this study. All of the VRE isolates and 16(53.3%) of 30VSE isolates were identified as E.faecium, while the remaining 14(46.7%) isolates were identified as E.faecalis. The susceptibility patterns of the isolates to linezolid, daptomycin, quinupristin-dalfopristin and tigecycline were determined by the E-test method, and the MIC values were interpreted according to CLSI and for tigecycline  EUCAST recommendations. The rates of susceptible isolates were 100%for daptomycin, 81%for linezolid, 75%for tigecycline and 20%for quinupristin-dalfopristin. All of the VSE isolates were susceptible to linezolid and daptomycin; 53%of them were susceptible to tigecycline; 47%were susceptible to quinupristin-dalfopristin. The most active agent against VRE isolates was daptomycin, followed by tigecycline and linezolid in our unit.

Keywords

Vancomycin resistant enterococci, Linezolid, Daptomycin, Quinupristin-dalfopristin, Tigecycline

Article Metrics

Article View: 778

Share This Article

© The Author(s) 2014. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.